1H-Pyrrole-1-propanamide, N-[19-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-15,19-dioxo-3,6,9,12-tetraoxa-16-azanonadec-1-yl]-2,5-dihydro-2,5-dioxo- (ACI)

SINOPEG is serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply).    SINOPEG holds 40 IP, 80+ pending IP, 20+ DMFs that meet FDA requirements.  The company has IS0 9001/1S0 13485/1S0 14001/1S0 45001 certification.  The laboratory and production workshop are designed and built in accordance with the cGMP standard of FDA.  We follow the requirements of ICH-Q7A to organize production at scale, to provide high quality drug delivery products and services to customers globally.

Please contact us at sales@sinopeg.com for PEG derivatives.   Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis.   Please contact us at sales@sinopeg.com for quotation and availability.